BioDelivery Sciences Jumps 51% As Collegium Confirms Premium Acquisition Deal
(Collegium) Shares of BioDelivery Sciences International, Inc rose more than 51% on Monday on the news of the acquisition by Collegium Pharmaceutical Inc. at $5.60 per share. Following the deal,…